These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36769345)

  • 1. RANKL-RANK-OPG Pathway in Charcot Diabetic Foot: Pathophysiology and Clinical-Therapeutic Implications.
    Greco T; Mascio A; Comisi C; Polichetti C; Caravelli S; Mosca M; Mondanelli N; Troiano E; Maccauro G; Perisano C
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates on the role of receptor activator of nuclear factor κB/receptor activator of nuclear factor κB ligand/osteoprotegerin pathway in breast cancer risk and treatment.
    Bayer CM; Beckmann MW; Fasching PA
    Curr Opin Obstet Gynecol; 2017 Feb; 29(1):4-11. PubMed ID: 28002265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss.
    Trouvin AP; Goëb V
    Clin Interv Aging; 2010 Nov; 5():345-54. PubMed ID: 21228900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment.
    Molines L; Darmon P; Raccah D
    Diabetes Metab; 2010 Sep; 36(4):251-5. PubMed ID: 20570543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives.
    Infante M; Fabi A; Cognetti F; Gorini S; Caprio M; Fabbri A
    J Exp Clin Cancer Res; 2019 Jan; 38(1):12. PubMed ID: 30621730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients.
    Folestad A; Ålund M; Asteberg S; Fowelin J; Aurell Y; Göthlin J; Cassuto J
    Acta Orthop; 2015; 86(4):415-25. PubMed ID: 25811776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The participation of RANK, RANKL and OPG in tumor osteolysis].
    Stanisławowski M; Kmieć Z
    Postepy Hig Med Dosw (Online); 2009 May; 63():234-41. PubMed ID: 19502684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of the RANKL/RANK/OPG system.
    Yasuda H
    J Bone Miner Metab; 2021 Jan; 39(1):2-11. PubMed ID: 33389131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-based assay strategy for identification of motif-specific RANK signaling pathway inhibitors.
    Chen T; Feng X
    Assay Drug Dev Technol; 2006 Aug; 4(4):473-82. PubMed ID: 16945019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease Burden.
    de Castro LF; Burke AB; Wang HD; Tsai J; Florenzano P; Pan KS; Bhattacharyya N; Boyce AM; Gafni RI; Molinolo AA; Robey PG; Collins MT
    J Bone Miner Res; 2019 Feb; 34(2):290-294. PubMed ID: 30496606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy.
    Ndip A; Williams A; Jude EB; Serracino-Inglott F; Richardson S; Smyth JV; Boulton AJ; Alexander MY
    Diabetes; 2011 Aug; 60(8):2187-96. PubMed ID: 21659498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand.
    Mabilleau G; Petrova NL; Edmonds ME; Sabokbar A
    Diabetologia; 2008 Jun; 51(6):1035-40. PubMed ID: 18389210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denosumab: RANKL inhibition in the management of bone loss.
    Hamdy NA
    Drugs Today (Barc); 2008 Jan; 44(1):7-21. PubMed ID: 18301800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
    Armada L; Marotta Pdos S; Pires FR; Siqueira JF
    J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes.
    Kondegowda NG; Filipowska J; Do JS; Leon-Rivera N; Li R; Hampton R; Ogyaadu S; Levister C; Penninger JM; Reijonen H; Levy CJ; Vasavada RC
    Sci Adv; 2023 Nov; 9(44):eadf5238. PubMed ID: 37910614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy.
    Gifre L; Ruiz-Gaspà S; Carrasco JL; Portell E; Vidal J; Muxi A; Monegal A; Guañabens N; Peris P
    Osteoporos Int; 2017 Sep; 28(9):2707-2715. PubMed ID: 28580511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The high rate of bone resorption in multiple myeloma is due to RANK (receptor activator of nuclear factor-kappaB) and RANK Ligand expression.
    Roux S; Mariette X
    Leuk Lymphoma; 2004 Jun; 45(6):1111-8. PubMed ID: 15359989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab.
    Lacey DL; Boyle WJ; Simonet WS; Kostenuik PJ; Dougall WC; Sullivan JK; San Martin J; Dansey R
    Nat Rev Drug Discov; 2012 May; 11(5):401-19. PubMed ID: 22543469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids.
    Atilano-Miguel S; Barbosa-Cortés L; Ortiz-Muñiz R
    Bol Med Hosp Infant Mex; 2022; 79(5):275-283. PubMed ID: 36264895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis.
    Wittrant Y; Théoleyre S; Chipoy C; Padrines M; Blanchard F; Heymann D; Rédini F
    Biochim Biophys Acta; 2004 Sep; 1704(2):49-57. PubMed ID: 15363860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.